1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This program’s application page is no longer available.
Historical funding: Varies
Prior eligibility: Universities and research institutions.
Biotechnology Resource Grants (P41) is sponsored by NIH. Provides support for biotechnology resources available to all qualified investigators, regardless of their scientific disciplines or disease orientations.
NIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read articleNIH has no active SBIR or STTR omnibus solicitations for the first time in a decade. The FY26 reset reposts the omnibus series on June 1 with a September 8 deadline and a quietly historic change — Direct-to-Phase II STTR awards. Here is the strategy.
Read articleNIH posted PAR-27-032 — Maximizing Investigators' Research Award for Early Stage Investigators — on May 12 as the first NOFO under the HHS SimplerNOFO initiative. Plain language, checklists, restructured sections, and explicit guidance replace the dense traditional NIH announcement. What the redesign means for grant writing strategy across HHS and which NOFOs are next in line.
Read article